ertain delays beyond bioMETRX'scontrol with respect to market acceptance of their technology and/orproducts whether financing will be available the effect of theapplication of acquisition accounting policies as well as certain otherrisk factors which are and may be detailed from time to time in bioMETRX'sfilings with the Securities and Exchange Commission.
Date:12/13/2007